Stockreport

Novartis Agrees Up to $2B Excellergy Deal Amid Generic Pressure [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF Novartis ( NYSE:NVS ) is leaning further into immunology, agreeing to acquire biotech firm Excellergy Inc. for up to $2 billion as it looks to reinforce its pipeline in [Read more]